Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Premier Research Group | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Premier Research Group

Troy W. McCall, Ph.D. has been promoted from chief operating officer to chief executive officer at Premier Research Group, effective immediately.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Troy W. McCall, Ph.D. has been promoted from chief operating officer to chief executive officer at Premier Research Group, effective immediately. He replaces Dr. Simon Yaxley, who will transition to an advisory role with the company’s board of directors as deputy chairman.

Michael Barry, non-executive chairman of the board, said, “On behalf of the board, I would like to thank Dr. Yaxley for his efforts, commitment to excellence, and vision as CEO and co-founder of Premier Research. Dr. McCall’s commitment, drive, and deep understanding of the business make him the ideal successor to ensure that Premier Research maintains its outstanding track record of growth and customer service.”

Dr. McCall led the successful integration of four acquisitions, established a global organization, and achieved year-on-year growth in excess of 20%.During Dr. McCall’s tenure, the company also initiated support of medical device trials in the U.S., launched a Functional Sourcing group, expanded clinical research sites, and completed its first NDA submission on behalf a sponsor.

Dr. Yaxley commented, “It is exciting and rewarding to have Troy stepping into the CEO role.This is what we have been working together towards and he deserves the recognition.I can think of no one more suited to continue to grow this successful company we, and many others, have worked hard to create.I also look forward to my continued involvement in the business as we continue to grow both organically as well as through acquisition.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters